Literature DB >> 21035608

Selection of aptamers for a non-DNA binding protein in the context of cell lysate.

Mirzo Kanoatov1, Sahar Javaherian, Sergey N Krylov.   

Abstract

Aptamer-facilitated Protein Isolation from Cells (AptaPIC) is a recently introduced method that allows, in particular, generation of aptamers for a protein target in a context of a crude cell lysate. The approach enables efficient, tag-free, affinity purification of target proteins which are not available in a pure form a priori, and for which no affinity ligands are available. In the proof-of-principle work, AptaPIC was used to develop aptamers for and purify MutS, a DNA mismatch repair protein. The DNA-binding nature of MutS raised concerns that AptaPIC was not a generic technique and could be inapplicable to protein targets that do not possess native nucleic acid-binding properties. Here we prove that these concerns are invalid. We used AptaPIC to generate pools of aptamers for human Platelet-Derived Growth Factor chain B (PDGF-B) protein, a non-DNA binding protein, in the context of a bacterial cell lysate, and subsequently purify it from the same lysate. Within a small number of rounds, the efficiencies of aptamer selection were similar in conventional Systematic Evolution of Ligands by Exponential Enrichment (SELEX) for pure protein and in AptaPIC for protein in the cell lysate. The conventional selection approach resulted in an aptamer pool with an EC(50) value of 2.0±0.1 μM, while the AptaPIC selection approach resulted in a pool with an EC(50) value of 3.9±0.4 μM. Our results clearly demonstrate that selection of aptamers for proteins in the cell lysate is not only realistic but also efficient.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035608     DOI: 10.1016/j.aca.2010.09.044

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  6 in total

1.  Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cells.

Authors:  Lindsay Jones Talbot; Zhiyong Mi; Syamal Dave Bhattacharya; Victoria Kim; Hongtao Guo; Paul C Kuo
Journal:  Surgery       Date:  2011-08       Impact factor: 3.982

Review 2.  Synthetic, Switchable Enzymes.

Authors:  Vic Norris; Sergey N Krylov; Pratul K Agarwal; Glenn J White
Journal:  J Mol Microbiol Biotechnol       Date:  2017-04-28

3.  Aptamers: problems, solutions and prospects.

Authors:  A V Lakhin; V Z Tarantul; L V Gening
Journal:  Acta Naturae       Date:  2013-10       Impact factor: 1.845

Review 4.  Aptamer in bioanalytical applications.

Authors:  Anton B Iliuk; Lianghai Hu; W Andy Tao
Journal:  Anal Chem       Date:  2011-05-05       Impact factor: 6.986

Review 5.  Capillary electrophoresis applied to DNA: determining and harnessing sequence and structure to advance bioanalyses (2009-2014).

Authors:  Brandon C Durney; Cassandra L Crihfield; Lisa A Holland
Journal:  Anal Bioanal Chem       Date:  2015-05-03       Impact factor: 4.142

6.  Vasorin is a potential serum biomarker and drug target of hepatocarcinoma screened by subtractive-EMSA-SELEX to clinic patient serum.

Authors:  Shaohua Li; Hui Li; Xiqin Yang; Wei Wang; Aixue Huang; Jie Li; Xingliang Qin; Fei Li; Guanyi Lu; Hongmei Ding; Xueting Su; Lvbin Hou; Wei Xia; Ming Shi; Hongwen Zhang; Qiang Zhao; Jie Dong; Xingfeng Ge; Leqiao Sun; Chenjun Bai; Chaonan Wang; Xuelian Shen; Tao Fang; Fusheng Wang; Heqiu Zhang; Ningsheng Shao
Journal:  Oncotarget       Date:  2015-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.